Skip to content

    Asthma Health Center

    Font Size
    A
    A
    A

    Omalizumab for Asthma - Topic Overview

    Omalizumab (Xolair) is a medicine approved by the U.S. Food and Drug Administration (FDA) for use in people age 12 and older who have moderate or severe persistent asthma. This medicine costs a lot more than any of the standard treatments for asthma.

    The medicine works by blocking immunoglobulin E (IgE) from attaching to allergens. When IgE attaches to an allergen, it sets off a process that leads to the symptoms of an allergic reaction.

    Recommended Related to Asthma

    Asthma Causes and Triggers

    No one really knows what causes asthma. What we do know is that asthma is a chronic inflammatory disease of the airways. The causes of asthma symptoms can vary from person to person. Still, one thing is consistent with asthma: when airways come into contact with an asthma trigger, the airways become inflamed, narrow, and fill with mucus. When you have an asthma attack, spasms of the muscles around the airways, inflammation and swelling of the mucosal membrane lining the airways, and excessive amounts...

    Read the Asthma Causes and Triggers article > >

    This medicine may help reduce asthma episodes, improve peak expiratory flow (PEF), and reduce the need for other medicines. It may also reduce emergency room visits and hospital stays. But more study is needed.

    Omalizumab is given as a shot. The dose depends on your body weight and IgE level.

    Your doctor may recommend this medicine if:

    • Your asthma is not well controlled after using inhaled corticosteroids and long-acting beta2-agonists or leukotriene pathway modifiers for 3 months. People who use oral or injected corticosteroids or who need high doses of inhaled corticosteroids for daily control can also consider using this medicine.
    • You have severe allergic asthma and your symptoms aren't relieved by avoiding allergens or taking other medicines.

    Severe allergic reactions, including anaphylaxis, can occur with omalizumab, but this is rare. So people who get this medicine are watched for 2 hours after they get their first 2 doses. They should also carry epinephrine in case they have an allergic reaction after treatment.

    WebMD Medical Reference from Healthwise

    Last Updated: /2, 14 1
    This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
    1
    Next Article:

    Omalizumab for Asthma Topics

    When Is Your Asthma Worse?

    When Is Your Asthma Worse?

    Take the WebMD Asthma assessment to get Personalized Action Plan

    Start Now

    Today on WebMD

    Lung and bronchial tube graphic
    5 common triggers.
    group jogging in park
    Should you avoid fitness activities?
     
    asthma inhaler
    Learn about your options.
    man feeling faint
    What’s the difference?
     
    Madison Wisconsin Capitol
    Slideshow
    woman wearing cpap mask
    Article
     
    red wine pouring into glass
    Slideshow
    Woman holding inhaler
    Quiz
     
    Man outdoors coughing
    Article
    Lung and bronchial tube graphic
    Article
     
    10 Worst Asthma Cities
    Slideshow
    runner
    Article